Advanced Diagnostic Laboratory

Advanced Diagnostic Laboratory was paid $6K by Medicaid between Dec 2021 and Oct 2024, across 28 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 28% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Texas

Rank by total paid#252 of 436

Median peer was paid$17K

This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	69	$1K
2022	275	$2K
2023	458	$2K
2024incomplete	475	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	28%	142	140	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	25%	122	111	$2K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	11%	23	22	$720.00
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	9.7%	26	26	$610.28
87481		4.3%	73	64	$272.25
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.8%	23	22	$240.00
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	3.6%	23	22	$225.24
87631		2.8%	60	57	$178.00
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	2.8%	72	68	$176.91
87640		<1%	121	110	$59.59
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	63	58	$57.49
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	177	175	$52.20

16 more codes

87541		<1%	46	$43.80
87486		<1%	60	$43.80
87581		<1%	60	$43.80
84443	Thyroid stimulating hormone (TSH)	<1%	15	$37.80
87653		<1%	15	$29.48
87511		<1%	15	$29.48
80061	Lipid panel	<1%	14	$24.12
80053	Comprehensive metabolic panel	<1%	16	$23.75
82728		<1%	12	$18.39
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	13	$14.00
83036	Hemoglobin; glycosylated (A1C)	<1%	16	$13.11
83735		<1%	12	$9.03
83540		<1%	13	$8.73
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	0%	15	$0.00
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	0%	15	$0.00
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCFADDEN, JOHN (MANAGING PARTNER)

Same official

Other billing entities under MCFADDEN, JOHN

Full network →

Provider	Location	Paid
Mcfadden Family Dentistry, P.C.	Martinsville, IN	$130K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.